Company Filing History:
Years Active: 2016-2020
Title: The Innovations of Lawrence H Young
Introduction
Lawrence H Young is a notable inventor based in Woodbridge, CT (US). He has made significant contributions to the field of medical research, particularly in the area of metabolic disorders. With a total of 2 patents, his work focuses on innovative methods for treating conditions related to AMPK activity and ischemia-reperfusion injury.
Latest Patents
One of his latest patents is titled "Use of MIF and MIF pathway agonists." This invention relates to novel methods and compositions for increasing AMPK activity and glucose uptake. It involves administering a macrophage migration inhibitory factor (MIF) pathway agonist to subjects in need. The invention also includes methods for selecting subjects for treatment with MIF agonists and identifying those at risk for conditions where increased AMPK activity is beneficial.
Another significant patent is "Methods of administering D-dopachrome tautomerase (D-DT) to treat ischemia-reperfusion injury." This invention highlights the association between reduced levels of D-DT and ischemia-reperfusion injury. It presents methods for administering D-DT and recombinant D-DT as a treatment for this condition.
Career Highlights
Lawrence H Young is affiliated with Yale University, where he conducts his research and develops his inventions. His work has garnered attention for its potential impact on treating metabolic disorders and improving patient outcomes.
Collaborations
One of his notable collaborators is Richard J Bucala, with whom he has worked on various research projects. Their combined expertise has contributed to advancements in understanding the MIF pathway and its implications in medical treatments.
Conclusion
Lawrence H Young's innovative work and patents reflect his commitment to advancing medical science. His contributions have the potential to significantly improve treatment options for patients suffering from metabolic disorders and ischemia-reperfusion injury.